transplant

Investors shrug off reports of Steve Jobs' liver transplant - San Jose Mercury News border=

Investors shrug off reports of Steve Jobs' liver transplant - San Jose Mercury News

San Jose Mercury News,  USA
By John Boudreau Investors on Monday seemed to shrug off news that Apple CEO Steve Jobs is recovering from a liver transplant. Apple's shares closed down 1.5 percent, but that was amid a broad sell-off on Wall Street that left the Dow down 2.4 percent …
Bloomberg
Digital Media Wire
The Industry Standard
 -

Transplant can reduce Apple CEO Steve Jobs' cancer risk, Stanford... - San Jose Mercury News border=

Transplant can reduce Apple CEO Steve Jobs' cancer risk, Stanford… - San Jose Mercury News

San Jose Mercury News,  USA
Liver transplants are rejected less vigorously than transplants of other organs, such as hearts or kidneys, according to longtime transplant surgeon Dr. Oscar Salvatierra of Stanford University's School of Medicine. As a result, treatment with …
Bloomberg
New York Times
ABC News
 -

Transplant can reduce Apple CEO Steve Jobs' cancer risk, Stanford ... - San Jose Mercury News border=

Transplant can reduce Apple CEO Steve Jobs' cancer risk, Stanford … - San Jose Mercury News

San Jose Mercury News,  USA
Liver transplants are rejected less vigorously than transplants of other organs, such as hearts or kidneys, according to longtime transplant surgeon Dr. Oscar Salvatierra of Stanford University's School of Medicine. As a result, treatment with …
Bloomberg
Health.com
Beliefnet.com